DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 124 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $545,815 | -37.2% | 42,910 | -30.5% | 0.00% | 0.0% |
| Q2 2023 | $868,975 | +15.3% | 61,717 | +26.6% | 0.00% | 0.0% |
| Q1 2023 | $753,388 | +28.6% | 48,763 | +36.5% | 0.00% | 0.0% |
| Q4 2022 | $585,648 | -11.0% | 35,732 | +0.4% | 0.00% | 0.0% |
| Q3 2022 | $658,000 | +41.2% | 35,573 | +0.6% | 0.00% | – |
| Q2 2022 | $466,000 | +37.5% | 35,346 | -3.4% | 0.00% | – |
| Q1 2022 | $339,000 | -0.6% | 36,573 | +4.6% | 0.00% | – |
| Q4 2021 | $341,000 | -71.0% | 34,975 | +1.2% | 0.00% | -100.0% |
| Q3 2021 | $1,176,000 | -0.3% | 34,571 | +7.3% | 0.00% | 0.0% |
| Q2 2021 | $1,179,000 | -9.1% | 32,218 | +11.3% | 0.00% | 0.0% |
| Q1 2021 | $1,297,000 | -68.0% | 28,951 | -59.2% | 0.00% | -50.0% |
| Q4 2020 | $4,053,000 | +27.7% | 71,008 | +14.7% | 0.00% | 0.0% |
| Q3 2020 | $3,175,000 | -27.6% | 61,884 | -15.7% | 0.00% | -33.3% |
| Q2 2020 | $4,385,000 | +422.6% | 73,421 | +260.3% | 0.00% | +200.0% |
| Q1 2020 | $839,000 | -55.0% | 20,376 | -31.9% | 0.00% | 0.0% |
| Q4 2019 | $1,864,000 | +283.5% | 29,942 | +109.3% | 0.00% | – |
| Q3 2019 | $486,000 | +111.3% | 14,307 | +144.0% | 0.00% | – |
| Q2 2018 | $230,000 | – | 5,863 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $69,030,000 | 15.95% |
| SV Health Investors, LLC | 449,951 | $25,679,000 | 12.37% |
| Sunesis Advisors, LLC | 96,299 | $5,496,000 | 4.45% |
| Redmile Group, LLC | 4,437,968 | $253,275,000 | 3.07% |
| Consonance Capital Management LP | 484,671 | $27,660,000 | 2.58% |
| SECTORAL ASSET MANAGEMENT INC | 488,842 | $27,898,000 | 1.97% |
| Opaleye Management Inc. | 222,000 | $12,670,000 | 1.66% |
| Eversept Partners, LP | 246,240 | $14,052,917 | 1.65% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 38,620 | $2,204,000 | 1.28% |
| Avoro Capital Advisors LLC | 1,300,000 | $74,191,000 | 1.28% |